Huei K. Lin

A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors

C. Cleeland, Z. Estrov, H. Kantarjian, 2018, Cancer medicine.

A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

C. Cleeland, T. Mendoza, H. Kantarjian, 2015 .